Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating cannabidiol for pelvic pain in endometriosis was terminated. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Sao Paulo | Conditions: Endometriosis, Pelvic Pain | Phase 2, Phase 3 | Status: TERMINATED